<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>7662916</identifier>
<setSpec>1022-5129</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Zumaeta, E</dc:author>
<dc:author>Ramírez Albajés, V</dc:author>
<dc:author>Ferrándiz, J</dc:author>
<dc:author>González Griego, A</dc:author>
<dc:author>Figueroa, R</dc:author>
<dc:description xml:lang="en">The immune response to cuban recombinant Hepatitis B vaccine was studied (sero conversion, sero protection, hyper response and geometric median) in 211 health workers from different general hospitals of Peruvian Social Security, along the coast of Perú. Vaccine was given by deltoid intramuscular injection at 0-1-2 months interval. Quantification of Anti HBS was done according to Organon Tecknica Methodology. Sero protection was obtained in 97% of people studied just at days of the first injection. Women less than 40 years old showed better immunogenic response. This Hepatitis B Vaccine program is recommended due to its symmetry, short time course and high immune protection obtained.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1995 May-Aug </dc:date>
<dc:title xml:lang="es">Vacuna recombinante contra la hepatitis viral B en trabajadores de la salud del Instituto Peruano de la Seguridad Social.</dc:title>
<dc:title xml:lang="en">[Recombinant hepatitis B vaccine in health personnel of the Peruvian Institute of Social Security].</dc:title>
<dc:publisher>Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru</dc:publisher>
</metadata>
</record>
</pubmed-document>
